Elective surgery volume expected to make full recovery in 2023-24 Mon, 23rd Jan 2023 Article tags Cardiovascular surgeryOrthopaedic & Spine SurgerySurgical deviceAsiaCardiovascular SurgeryOrthopaedic & Spine SurgerySurgical GatewaySurgical Procedure Volume Segmentation Clearstate estimates that it will take until early 2024 to see elective surgery volume in Asia-Pacific (APAC) returning to pre-pandemic levels. Elective surgery volume is recovering, but remains below pre-pandemic levels. In 2021 and 2022, we saw a respite in the contraction of elective surgery volume with increased vaccination rates and gradual reopening of economies in APAC. This led to a rebound in elective procedures during the post-vaccine period of 2021. However elective surgery volume has not fully recovered to pre-pandemic levels. Hospitals are struggling to clear the large backlog of surgery cases because of manpower challenges and capacity issues. Inside Asia-Pacific’s surgical device market As the APAC surgical device market makes a full recovery from covid-19 impact and navigates changes, companies need to adapt their market strategy accordingly. Uncover post-pandemic recovery trends and the future outlook of APAC’s surgical device market in our latest whitepaper. Surgical GatewayThe go-to source for surgical procedure volumes and surgical devices market size, share and growth data for 197 procedures and 125 devices group globally. Find out more Mon, 23rd Jan 2023 Article tags Cardiovascular surgeryOrthopaedic & Spine SurgerySurgical deviceAsiaCardiovascular SurgeryOrthopaedic & Spine SurgerySurgical GatewaySurgical Procedure Volume Segmentation
Surgical GatewayThe go-to source for surgical procedure volumes and surgical devices market size, share and growth data for 197 procedures and 125 devices group globally. Find out more